| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
32,633,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,434,166 |
Avg
Vol: |
653,792 |
| 52
Week Range: |
$21.74 - $21.74 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2012-02-17 |
4 |
A |
$2.93 |
$29,300 |
D/D |
10,000 |
53,896 |
|
- |
|
| Frost Mark T |
Chief Financial Officer |
• – – |
2012-02-17 |
4 |
A |
$2.93 |
$39,066 |
D/D |
13,333 |
76,266 |
|
- |
|
| Henderson Lori M |
VP, general counsel |
• – – |
2012-02-17 |
4 |
A |
$2.93 |
$34,181 |
D/D |
11,666 |
39,232 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2012-02-17 |
4 |
A |
$2.93 |
$29,300 |
D/D |
10,000 |
37,565 |
|
- |
|
| Leung Gabriel |
Director |
– • – |
2011-12-07 |
4 |
B |
$2.34 |
$9,360 |
D/D |
4,000 |
13,254 |
2.39 |
- |
|
| Henderson Lori M |
VP, general counsel |
• – – |
2011-12-07 |
4 |
B |
$2.47 |
$14,573 |
D/D |
5,900 |
27,566 |
2.74 |
- |
|
| Leung Gabriel |
Director |
– • – |
2011-12-06 |
4 |
B |
$2.45 |
$9,800 |
D/D |
4,000 |
9,254 |
2.39 |
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2011-11-14 |
4 |
S |
$2.62 |
$1,001 |
D/D |
(382) |
27,565 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2011-11-04 |
4 |
S |
$3.11 |
$3,542 |
D/D |
(1,139) |
27,947 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, CEO & President |
• • • |
2011-06-02 |
4 |
A |
$5.25 |
$139,997 |
D/D |
26,666 |
4,631,234 |
|
- |
|
| Frost Mark T |
Chief Financial Officer |
• – – |
2011-06-02 |
4 |
A |
$5.25 |
$69,998 |
D/D |
13,333 |
52,933 |
|
- |
|
| Henderson Lori M |
VP, general counsel |
• – – |
2011-06-02 |
4 |
A |
$5.25 |
$61,247 |
D/D |
11,666 |
21,666 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2011-06-02 |
4 |
A |
$5.25 |
$52,500 |
D/D |
10,000 |
41,069 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2011-06-02 |
4 |
A |
$5.25 |
$52,500 |
D/D |
10,000 |
29,086 |
|
- |
|
| Anderson Paul S |
Director |
– • – |
2011-06-01 |
4 |
A |
$5.14 |
$14,999 |
D/D |
2,918 |
13,353 |
|
- |
|
| Jordan Veronica Gh |
Director |
– • – |
2011-06-01 |
4 |
A |
$5.14 |
$14,999 |
D/D |
2,918 |
17,081 |
|
- |
|
| Leung Gabriel |
Director |
– • – |
2011-06-01 |
4 |
A |
$5.14 |
$14,999 |
D/D |
2,918 |
5,254 |
|
- |
|
| Oconnor Kevin |
Director |
– • – |
2011-06-01 |
4 |
A |
$5.14 |
$20,000 |
D/D |
3,891 |
18,353 |
|
- |
|
| Ryan Una S |
Director |
– • – |
2011-06-01 |
4 |
A |
$5.14 |
$14,999 |
D/D |
2,918 |
13,817 |
|
- |
|
| Roth Arthur J |
Director |
– • – |
2011-06-01 |
4 |
A |
$5.14 |
$10,280 |
D/D |
2,000 |
20,000 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2011-05-06 |
4 |
S |
$4.84 |
$958 |
D/D |
(198) |
19,086 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2011-05-06 |
4 |
S |
$4.84 |
$1,147 |
D/D |
(237) |
31,069 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2011-03-18 |
4 |
S |
$4.18 |
$2,579 |
D/D |
(617) |
19,284 |
|
- |
|
| Sargent Bruce J |
Sr VP, Drug Discovery |
• – – |
2011-03-18 |
4 |
S |
$4.18 |
$3,607 |
D/D |
(863) |
31,306 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2011-03-07 |
4 |
S |
$4.46 |
$388 |
D/D |
(87) |
19,901 |
|
- |
|
620 Records found
|
|
Page 18 of 25 |
|
|
